News & Updates
Filter by Specialty:
Weight gain tied to hypertension in patients on methadone maintenance treatment
The occurrence of hypertension in patients with opioid use disorder receiving methadone maintenance treatment (MMT) is associated with weight gain, reports a study.
Weight gain tied to hypertension in patients on methadone maintenance treatment
16 Jul 2024
Pemvidutide gains MOMENTUM in phase II obesity trial
Pemvidutide, an investigational, peptide-based GLP-1/glucagon dual receptor agonist, gains traction in the booming obesity drug market, delivering significant weight loss reductions in nondiabetic individuals with overweight or obesity in the phase II MOMENTUM trial.
Pemvidutide gains MOMENTUM in phase II obesity trial
16 Jul 2024
Tofacitinib shows good retention rates in PsA patients
Tofacitinib demonstrates safety and persistence in patients with psoriatic arthritis (PsA) who are mostly refractory to biologic and oral targeted synthetic disease-modifying antirheumatic drugs, results of a study have shown.
Tofacitinib shows good retention rates in PsA patients
15 Jul 2024
Semaglutide may improve NYHA functional class in obesity-related HFpEF
Patients with obesity-related heart failure with preserved ejection fraction (HFpEF) treated with semaglutide are more likely to show an improvement in NYHA functional class at 52 weeks than those who received placebo, according to a study.
